Rethinking big pharma The beginning of a year is always a good time to indulge in a little apocalyptic musing. So how did the pharmaceutical industry look as 2007 bowed out, and how should the business model be re-shaped? asks Peter Mansell
Time to bury the hatchet While sales and marketing may not have been the closest of friends in the past, it is time the two sectors buried the hatchet and worked together to maximise business outcome, says Mark Greener
Marketing’s high flyers Marketers face testing times in a market and industry that continues to change focus. The one constant is PharmaTimes Marketeer of the Year competition, as Selina McKee reports
The creative touch Healthcare advertising in general suffers from being too rationally based, but creativity enables companies to build strong brands and differentiate where there is no rational difference, finds Peter Mansell
Therapeutic focus: HIV/AIDS Since it was first reported 27 years ago, HIV/AIDS has seldom been out of the headlines. Michael Day looks at some of the recent developments in treating this still growing pandemic
No comments:
Post a Comment